カテゴリ： GlobalData, アメリカ, 企業調査

Merck & Co Inc (MRK)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Merck & Co Inc (MRK) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011104
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月21日
◆ページ数：141
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products. It offers prescription products for treating cardiovascular, cancer, immunology, infectious, respiratory and women’s diseases, diabetes and vaccines. The company provides animal health products including vaccines, poultry products, livestock products and aquaculture products. Merck sells pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers; and animal health products to veterinarians, distributors and animal producers. The company’s operations outside the US are conducted primarily through subsidiaries. It offers its products in US, Europe, Middle East and Africa, Asia Pacific, Japan, Latin America and other countries. Merck is known as MSD outside the US and Canada and is headquartered in Kenilworth, New Jersey, the US.

Merck & Co Inc (MRK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Merck & Co Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Merck & Co Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Merck & Co Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Merck & Co Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Merck & Co Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Merck & Co Inc, Medical Equipment, Deal Details 18
Venture Financing 18
Grail Raises USD914 Million in First Tranche of Series B Financing 18
Livongo Health Raises USD44.5 Million in Series C Financing Round 21
WellDoc Raises USD22 Million in First Tranche of Series B Financing 23
CareSync Raises USD18 Million in Series B Financing 24
Navigating Cancer Raises USD10 Million in Financing Round 25
RaNA Therapeutics Raises USD55 Million in series B Financing 26
MedCPU Raises USD8 Million in Financing Round 27
ClearData Networks Raises USD25 Million in Series C Financing 28
Liaison Technologies Raises Funds through Venture Financing 29
Daktari Diagnostics Raises USD15.5 Million in Series D Financing 30
Aventura Raises USD14 Million in Series C Financing 31
WiserTogether Raises USD9 Million in Series B Venture Financing 32
Healthsense Raises USD10 Million in Venture Financing 33
ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 34
MedCPU Raises USD9.3 Million in Series B Financing 35
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 36
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 37
WellDoc Raises US$15.7 Million In Venture Financing 38
ClearData Networks Raises US$14 Million In Series B Financing 39
GenomeDx Biosciences Raises Funds Through Series B Financing 40
PatientSafe Solutions Raises US$27 Million In Series C Venture Financing 41
Aviir Raises US$20 Million In Venture Financing 43
eHealth Technologies Raises US$6 Million In Series D Financing 45
Remedy Informatics Raises US$6 Million In Venture Financing 46
Healthsense Raises US$7 Million In Series D Financing 47
Liaison Technologies Raises US$30 Million In Venture Financing 48
Physicians Interactive Holdings Secures US$8.5 Million In Venture Financing 49
Aviir Secures US$10 Million In Venture Financing 50
Daktari Diagnostics Secures US$5 Million In Venture Financing 51
HTG Molecular USD0.5 Million in Second Tranche of Series D Financing 52
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round 53
HTG Molecular Raises USD15.7 Million in First Tranche of Series D Financing 54
Private Equity 55
Merck Global Health Acquires Physicians Interactive From Perseus 55
Partnerships 56
Cerveau Technologies Enters into Licensing Agreement with Merck 56
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 57
Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology 58
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 59
CogState Enters Into Licensing Agreement With Merck Canada For Cognition Test 60
OpGen Enters into Research Agreement with Merck 61
Takeda Pharma Enters into Agreement with Koneksa Health 62
Merck Enters into Co-Development Agreement with Amoy Diagnostics 63
Enigma Biomedical Enters into Research Agreement with Biogen and Merck 64
Merck to Enter into Co-Development Agreement with Biocartis 65
Daktari Diagnostics Enters into Agreement with Merck 66
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 67
Dako Enters into Agreement with Merck for Companion Diagnostic Test 68
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 69
Physicians Interactive Enters Into Agreement With Greenway For eCoupon 70
Merck Enters Into Co-Development Agreement With Geisinger Health System 71
Ezose Sciences Enters Into Co-Development Agreement With Merck 72
F. Hoffmann-La Roche Enters Into Co-Development Agreement With Merck 73
Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 74
Equity Offering 75
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 75
VirtualScopics Completes First Tranche Of Private Placement Of Shares For US$3 Million 77
Debt Offering 78
Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 78
Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 79
Acquisition 80
OpGen Acquires AdvanDx 80
Physicians Interactive Acquires Tomorrow Networks 81
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 82
Physicians Interactive Acquires InfoMedics, Provider Of Patient Feedback Solutions 84
Merck & Co Inc – Key Competitors 85
Merck & Co Inc – Key Employees 86
Merck & Co Inc – Locations And Subsidiaries 88
Head Office 88
Other Locations & Subsidiaries 88
Joint Venture 111
Recent Developments 112
Strategy And Business Planning 112
Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin 112
Financial Announcements 113
Oct 27, 2017: Merck Announces Third-Quarter 2017 Financial Results 113
Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results 116
May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 119
Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 121
Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 123
May 05, 2016: Merck Announces First-Quarter 2016 Financial Results 126
Feb 03, 2016: Merck Announces Fourth-Quarter and Full-Year 2015 Financial Results 128
Corporate Communications 131
Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 131
Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 132
Mar 07, 2016: Merck Names Sanat Chattopadhyay President of Merck Manufacturing Division; Will Succeed Willie A. Deese Who Will Retire 133
Legal and Regulatory 134
Jan 15, 2016: Merck Sues Merck for Improper Use of “Merck” 134
Government and Public Interest 135
Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 135
Product News 136
Sep 27, 2016: IDH and CIC Mutations Provide Prognostic Information for Grade II and III Gliomas 136
May 05, 2016: Preliminary results comparing PD-L1 IHC diagnostic assays in lung cancer released 137
Apr 14, 2016: Quest Launches New Hepatitis C Virus Test Capabilities for Recently FDA-approved Antiviral Therapies 138
Other Significant Developments 139
Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 139
Jun 08, 2016: Merck Expands its Investment Fund Merck Ventures 140
Appendix 141
Methodology 141
About GlobalData 141
Contact Us 141
Disclaimer 141

List of Tables
Merck & Co Inc, Medical Equipment, Key Facts, 2016 2
Merck & Co Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Merck & Co Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Merck & Co Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Merck & Co Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Merck & Co Inc, Deals By Market, 2011 to YTD 2017 11
Merck & Co Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Grail Raises USD914 Million in First Tranche of Series B Financing 18
Livongo Health Raises USD44.5 Million in Series C Financing Round 21
WellDoc Raises USD22 Million in First Tranche of Series B Financing 23
CareSync Raises USD18 Million in Series B Financing 24
Navigating Cancer Raises USD10 Million in Financing Round 25
RaNA Therapeutics Raises USD55 Million in series B Financing 26
MedCPU Raises USD8 Million in Financing Round 27
ClearData Networks Raises USD25 Million in Series C Financing 28
Liaison Technologies Raises Funds through Venture Financing 29
Daktari Diagnostics Raises USD15.5 Million in Series D Financing 30
Aventura Raises USD14 Million in Series C Financing 31
WiserTogether Raises USD9 Million in Series B Venture Financing 32
Healthsense Raises USD10 Million in Venture Financing 33
ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 34
MedCPU Raises USD9.3 Million in Series B Financing 35
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 36
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 37
WellDoc Raises US$15.7 Million In Venture Financing 38
ClearData Networks Raises US$14 Million In Series B Financing 39
GenomeDx Biosciences Raises Funds Through Series B Financing 40
PatientSafe Solutions Raises US$27 Million In Series C Venture Financing 41
Aviir Raises US$20 Million In Venture Financing 43
eHealth Technologies Raises US$6 Million In Series D Financing 45
Remedy Informatics Raises US$6 Million In Venture Financing 46
Healthsense Raises US$7 Million In Series D Financing 47
Liaison Technologies Raises US$30 Million In Venture Financing 48
Physicians Interactive Holdings Secures US$8.5 Million In Venture Financing 49
Aviir Secures US$10 Million In Venture Financing 50
Daktari Diagnostics Secures US$5 Million In Venture Financing 51
HTG Molecular USD0.5 Million in Second Tranche of Series D Financing 52
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round 53
HTG Molecular Raises USD15.7 Million in First Tranche of Series D Financing 54
Merck Global Health Acquires Physicians Interactive From Perseus 55
Cerveau Technologies Enters into Licensing Agreement with Merck 56
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 57
Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology 58
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 59
CogState Enters Into Licensing Agreement With Merck Canada For Cognition Test 60
OpGen Enters into Research Agreement with Merck 61
Takeda Pharma Enters into Agreement with Koneksa Health 62
Merck Enters into Co-Development Agreement with Amoy Diagnostics 63
Enigma Biomedical Enters into Research Agreement with Biogen and Merck 64
Merck to Enter into Co-Development Agreement with Biocartis 65
Daktari Diagnostics Enters into Agreement with Merck 66
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 67
Dako Enters into Agreement with Merck for Companion Diagnostic Test 68
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 69
Physicians Interactive Enters Into Agreement With Greenway For eCoupon 70
Merck Enters Into Co-Development Agreement With Geisinger Health System 71
Ezose Sciences Enters Into Co-Development Agreement With Merck 72
F. Hoffmann-La Roche Enters Into Co-Development Agreement With Merck 73
Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 74
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 75
VirtualScopics Completes First Tranche Of Private Placement Of Shares For US$3 Million 77
Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 78
Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 79
OpGen Acquires AdvanDx 80
Physicians Interactive Acquires Tomorrow Networks 81
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 82
Physicians Interactive Acquires InfoMedics, Provider Of Patient Feedback Solutions 84
Merck & Co Inc, Key Competitors 85
Merck & Co Inc, Key Employees 86
Merck & Co Inc, Subsidiaries 88
Merck & Co Inc, Joint Venture 111

★海外企業調査レポート[Merck & Co Inc (MRK)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Enzo Clinical Labs Inc-医療機器分野：企業M&A・提携分析
    Summary Enzo Clinical Labs Inc (Enzo Clinical), a subsidiary of Enzo Biochem Inc is a medical laboratory that offers testing services. The laboratory develops technologies in the areas of gene regulation and gene modification, biomedical and pharmaceutical research markets. It offers physicians seve …
  • Prime Polymer Co Ltd：企業の戦略的SWOT分析
    Prime Polymer Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Ono Pharmaceutical Co., Ltd.：企業のM&A・事業提携・投資動向
    Ono Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ono Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • EDF Renewable Energy Inc-エネルギー分野：企業M&A・提携分析
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. The company designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It …
  • Centre for Drug Research and Development：製薬・医療：M&Aディール及び事業提携情報
    Summary Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides scientific infrastructure to transform discoveries into innovative therapeutic products and improved health outcomes. The center's drug development platform includes target valida …
  • Global Power Equipment Group Inc-エネルギー分野：企業M&A・提携分析
    Summary Global Power Equipment Group Inc (Global Power) is a power company that manufactures and distributes auxiliary equipment. The company offers products such as gas and steam turbine auxiliary products, control houses and generator enclosures. It provides repair and maintenance, modification an …
  • Ecclesiastical Insurance Office plc：戦略・SWOT・企業財務分析
    Ecclesiastical Insurance Office plc - Strategy, SWOT and Corporate Finance Report Summary Ecclesiastical Insurance Office plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Astellas Pharma US Inc-製薬・医療分野：企業M&A・提携分析
    Summary Astellas Pharma US Inc (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a drug company that offers injections and tablets. The company offers products such as adenosine injections, regadenoson injection, tacrolimus ointment, tacrolimus extended-release capsules, tacrolimus capsules …
  • Birner Dental Management Services Inc (BDMS)：企業の財務・戦略的SWOT分析
    Summary Birner Dental Management Services Inc (Perfect Teeth) is a dental care service provider. The company offers dental care services such as orthodontics, pediatric dentistry, periodontics, perio protect, endodontics and oral surgery. It also offers fillings and aesthetic procedures, porcelain v …
  • Mednax Inc (MD)：医療機器：M&Aディール及び事業提携情報
    Summary Mednax Inc (Mednax) is a national medical group company, which operates a network of physician service providers. The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. Its network includes other pediatric subspecialists compri …
  • Gerdau S.A.：戦略・SWOT・企業財務分析
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Marac Electronics S.A.：企業の戦略・SWOT・財務情報
    Marac Electronics S.A. - Strategy, SWOT and Corporate Finance Report Summary Marac Electronics S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Genuine Parts Company (GPC)：企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Showa Shell Sekiyu KK (5002)：企業の財務・戦略的SWOT分析
    Showa Shell Sekiyu KK (5002) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Summit Midstream Partners LP (SMLP)：石油・ガス：M&Aディール及び事業提携情報
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • General Electric Co (GE)：電力：M&Aディール及び事業提携情報
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services ranging from aircraft engines, power generation and oil and gas production equipment to medical …
  • Honeywell International Inc (HON)：電力：M&Aディール及び事業提携情報
    Summary Honeywell International Inc. (Honeywell) is a diversified manufacturing and technology company. The company offers avionics, aircraft engines, systems and service solutions; environmental and combustion controls, sensing controls, security and life safety products and services, scanning and …
  • Aptinyx Inc-製薬・医療分野：企業M&A・提携分析
    Summary Aptinyx Inc (Aptinyx), formerly Enarex, Inc., is a biopharmaceutical company which focuses on the discovery and development of novel therapies for the treatment of brain and nervous system disorders. The company has a robust chemistry library with small molecule compounds which are designed …
  • Vascular Biogenics Ltd (VBLT)：企業の財務・戦略的SWOT分析
    Summary Vascular Biogenics Ltd (VBL Therapeutics) is a biopharmaceutical company. It discovers, develops and commercializes gene-therapy medicines for the treatment of cancer and inflammatory diseases. The company’s lead product candidate VB-111, a gene-based biologic agent is developed to treat rec …
  • BWP Trust：企業の戦略・SWOT・財務情報
    BWP Trust - Strategy, SWOT and Corporate Finance Report Summary BWP Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆